Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis-Reference-Cited by-同舟云学术

Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis

Published:2019-07 Issue:1 Volume:157 Page:227-241.e7
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Boni Carolina,Janssen Harry L.A.,Rossi Marzia,Yoon Seung Kew,Vecchi Andrea,Barili Valeria,Yoshida Eric M.,Trinh Huy,Rodell Timothy C.,Laccabue Diletta,Alfieri Arianna,Brillo Federica,Fisicaro Paola,Acerbi Greta,Pedrazzi Giuseppe^ORCID,Andreone Pietro,Cursaro Carmela,Margotti Marzia,Santoro Rosanna^ORCID,Piazzolla Valeria,Brunetto Maurizia R.,Coco Barbara^ORCID,Cavallone Daniela^ORCID,Zhao Yang,Joshi Adarsh,Woo Jacky,Lau Audrey H.,Gaggar Anuj,Subramanian G. Mani,Massetto Benedetta,Fung Scott,Ahn Sang Hoon,Ma Xiaoli,Mangia Alessandra,Ferrari Carlo

Funder

Gilead Sciences

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference25 articles.

1. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection;Lampertico;J Hepatol,2017

2. Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma;Saitta;Liver Int,2015

3. RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg;Wooddell;Sci Transl Med,2017

4. New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus;Durantel;J Hepatol,2016

5. Control of viral transcripts as a concept for future HBV therapies;Seeger;Curr Opin Virol,2018

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic vaccination with lentiviral vector in HBV-persistent mice and two inactive HBsAg carriers;Journal of Hepatology;2024-01

2. HBV Vaccines: Advances and Development;Vaccines;2023-12-18

3. The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma;Immunology;2023-12-14

4. Classifying hepatitis B therapies with insights from covalently closed circular DNA dynamics;Virologica Sinica;2023-12

5. HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV;JHEP Reports;2023-11